Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
12 Apr 24
DEF 14A
Definitive proxy
12 Apr 24
ARS
2023 FY
Annual report to shareholders
12 Apr 24
10-K
2023 FY
Annual report
7 Mar 24
8-K
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7 Mar 24
8-K
Other Events
13 Feb 24
8-K
Amendments to Articles of Incorporation or Bylaws
15 Dec 23
8-K
Entry into a Material Definitive Agreement
14 Dec 23
8-K
Other Events
6 Dec 23
8-K
Other Events
28 Nov 23
EFFECT
Notice of effectiveness
20 Nov 23
CORRESP
Correspondence with SEC
15 Nov 23
UPLOAD
Letter from SEC
15 Nov 23
S-3
Shelf registration
9 Nov 23
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business Updates
9 Nov 23
8-K
Other Events
1 Nov 23
8-K
Other Events
30 Oct 23
8-K
Other Events
26 Sep 23
8-K
Other Events
21 Aug 23
8-K
Phathom Pharmaceuticals Reports Second Quarter 2023 Results
10 Aug 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
Departure of Directors or Certain Officers
17 Jul 23
SC TO-I/A
Issuer tender offer statement (amended)
17 Jul 23
SC TO-C
Information about tender offer
15 Jun 23
8-K
Other Events
15 Jun 23
SC TO-I
Issuer tender offer statement
15 Jun 23
8-K
Other Events
12 Jun 23
8-K
Amendments to Articles of Incorporation or Bylaws
30 May 23
8-K
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock
24 May 23
424B5
Prospectus supplement for primary offering
24 May 23
424B5
Prospectus supplement for primary offering
23 May 23
8-K
Other Events
23 May 23
10-Q
2023 Q1
Quarterly report
10 May 23
8-K
Phathom Pharmaceuticals Reports First Quarter 2023 Results
10 May 23
DEFA14A
Additional proxy soliciting materials
13 Apr 23
DEF 14A
Definitive proxy
13 Apr 23
ARS
2022 FY
Annual report to shareholders
13 Apr 23
8-K
Other Events
4 Apr 23
PRE 14A
Preliminary proxy
31 Mar 23
Latest ownership filings
4
Molly Henderson
10 Apr 24
SC 13D/A
TAKEDA PHARMACEUTICAL CO LTD
10 Apr 24
SC 13D/A
TAKEDA PHARMACEUTICAL CO LTD
1 Apr 24
4
Terrie Curran
26 Mar 24
SC 13G/A
Carlyle Group Inc.
12 Feb 24
SC 13G/A
Invesco Ltd.
9 Feb 24
3
Initial statement of insider ownership
26 Jan 24
SC 13G/A
Medicxi Growth I LP
26 Jan 24
4
Change in insider ownership
25 Jan 24
SC 13D/A
TAKEDA PHARMACEUTICAL CO LTD
25 Jan 24
4
Molly Henderson
22 Jan 24
4
Azmi Nabulsi
22 Jan 24
4
Terrie Curran
22 Jan 24
4
Molly Henderson
21 Nov 23
4
Asit Parikh
8 Nov 23
4
Molly Henderson
3 Nov 23
4
Azmi Nabulsi
3 Nov 23
4
Terrie Curran
3 Nov 23
4/A
Molly Henderson
21 Jul 23
4
Molly Henderson
17 Jul 23
4
Terrie Curran
17 Jul 23
4
Azmi Nabulsi
17 Jul 23
4
Asit Parikh
5 Jun 23
4
Molly Henderson
5 Jun 23
4
James N Topper
30 May 23
4
Mark Stenhouse
30 May 23
4
David A Socks
30 May 23
4
Asit Parikh
30 May 23
4
HEIDI FIELDS
30 May 23
4
FRANK KARBE
30 May 23
4
MICHAEL F COLA
30 May 23
SC 13D/A
Frazier Life Sciences Public Fund, L.P.
26 May 23
4
Molly Henderson
23 May 23
SC 13D/A
Frazier Life Sciences Public Fund, L.P.
5 May 23
4
Asit Parikh
11 Apr 23
4
Azmi Nabulsi
11 Apr 23
4
Terrie Curran
7 Apr 23
4
Molly Henderson
7 Apr 23
SC 13G
Carlyle Group Inc.
9 Mar 23
4
Molly Henderson
3 Mar 23